• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Marine Biotech Market 2012-2016 - Product Image

Global Marine Biotech Market 2012-2016

  • Published: August 2013
  • Region: Global
  • 53 Pages
  • TechNavio

FEATURED COMPANIES

  • Aker BioMarine AS
  • CP Kelco
  • FMC Biopolymer AS
  • GlycoMar Ltd.
  • Mera Pharmaceuticals Inc.
  • Prolume Ltd.
  • MORE

The analysts forecast the Global Marine Biotech market to grow at a CAGR of 3.82 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the demand for natural products. The Global Marine Biotech market has also been witnessing increasing investments from venture capitalists. However, high R&D costs could pose a challenge to the growth of this market.

The report, the Global Marine Biotech Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Marine Biotech market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Aker BioMarine AS, Aqua Bio Technology ASA, Cyanotech Corp., and Royal DSM NV.

The other vendors mentioned in this report are ABL Biotechnologies Ltd., Aquapharm Biodiscovery Ltd., Biotech Marine, CP Kelco, Elan Corp. plc, FMC Biopolymer AS, Frutarom USA Inc., GeoMarine Biotechnologies, GlycoMar Ltd., Integrin READ MORE >

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global Marine Biotech Market
Market Size and Forecast
06.2 Global Biotechnology Market
06.3 Five Forces Analysis
07. Market Segmentation
07.1 Global Marine Biotech Market Segmentation by Products
Marine Biotech Market Segmentation 2012
Marine Biotech Market Segmentation 2012-2016
07.2 Global Marine Biomaterials Market
Market Size and Forecast
07.3 Global Marine Bioactive Substances Market
Market Size and Forecast
08. Geographical Segmentation
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Aker BioMarine AS
Business Overview
Business Segmentation
Key Information
Sales by Region
SWOT Analysis
16.2 Aqua Bio Technology ASA
Business Overview
Business Segmentation
Key Information
Sales by Region
SWOT Analysis
16.3 Cyanotech Corp.
Business Overview
Business Segmentation
Key Information
Sales by Region
SWOT Analysis
16.4 Royal DSM NV
Business Overview
Business Segmentation
Key Information
Sales by Region
SWOT Analysis
17. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Marine Biotech Market 2012-2016 (US$ billion)
Exhibit 3: Natural Products by Marine Organism 2012
Exhibit 4: Global Biotechnology Market 2012-2016 (US$ billion)
Exhibit 5: Share of Marine Biotech in the Global Biotechnology Market 2012
Exhibit 6: Global Biotechnology Market Forecast 2012-2016 by Segments
Exhibit 7: Global Marine Biotech Market Segmentation by Products
Exhibit 8: Description of Marine Biotech Products
Exhibit 9: Global Marine Biotech Market Segmentation by Products 2012
Exhibit 10: Global Marine Biotech Market Forecast by Segments 2012-2016
Exhibit 11: Global Marine Biomaterials Market 2012-2016 (US$ billion)
Exhibit 12: Global Biomaterials Market 2012-2016 (US$ billion)
Exhibit 13: Share of Marine Biomaterials Market in the Global Biomaterials Market 2012
Exhibit 14: Global Marine Bioactive Substances Market 2012-2016 (US$ billion)
Exhibit 15: Global Marine Biotech Market Segmentation by Geography 2012
Exhibit 16: Marine Biotech Market in the US 2012-2016 (US$ billion)
Exhibit 17: Business Segmentation of Aker BioMarine AS
Exhibit 18: Sales by Region of Aker BioMarine AS 2012
Exhibit 19: Business Segmentation of Aqua Bio Technology ASA
Exhibit 20: Sales by Region of Aqua Bio Technology ASA 2012
Exhibit 22: Business Segmentation of Cyanotech Corp. 2012
Exhibit 23: Sales by Region of Cyanotech Corp. 2012
Exhibit 25: Business Segmentation of Royal DSM NV
Exhibit 26: Sales by Region of Royal DSM NV 2012

Commenting on the report, an analyst from the team said: “The emergence of marine biotech in Europe is a major trend witnessed in the Global Marine Biotech market. While the US dominates the Global Marine Biotech market, Europe has also been making significant contributions to this market. With Europe recovering from the economic crisis, the country has been making steady investments in marine biotechnology. For instance, since 2000, the European Commission, along with the member and associated states, has worked toward the development of marine biotech research infrastructure such as providing increased access to research vessels, laboratories, or stations and integrating scientific communities for enhancing research activities. The Marine Biotech market in Europe is also witnessing the emergence of several small and medium sized enterprises that are making significant contributions to the R&D and introduction of novel marine-based products. In addition, the European Union research policy supports several collaborative projects in marine biotechnology.”

According to the report, the most important of the main drivers is the introduction of innovative products from marine sources. Such products offer solutions to a wide range of markets such as Medical, Skin Care, and Cosmetics. The introduction of marine-based products such as cosmetic ingredients, pharmaceutical products, and molecules such as enzymes, biopolymers, and biomaterials are driving the growth of the market.

Further, the report states that one of the key challenges in the market is the high R&D costs. The R&D of marine-based products requires an understanding of several sciences such as biology, chemistry, and environmental sciences. In addition, the development of a product takes several years, which in turn increases the overall R&D costs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

- Aker BioMarine AS
- Aqua Bio Technology ASA
- Cyanotech Corp.
- and Royal DSM NV.; ABL Biotechnologies Ltd.
- Aquapharm Biodiscovery Ltd.
- Biotech Marine
- CP Kelco
- Elan Corp. plc
- FMC Biopolymer AS
- Frutarom USA Inc.
- GeoMarine Biotechnologies
- GlycoMar Ltd.
- Integrin Advanced Biosystems
- Jinghua Marine Biological USA Inc.
- Lonza Group Ltd.
- Marinova
- Mera Pharmaceuticals Inc.
- New England Biolabs Inc.
- PharmaMar SA
- Prolume Ltd.
- Pronova BioPharma
- Sea Run Holdings Inc.
- Tequesta Marine Biosciences
- Verenium Corp.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos